$6000 a script: Mesothelioma victims pay while lung cancer sufferers get subsidised drug

Eileen Wood
Updated November 19 2018 - 7:22am, first published November 2 2018 - 11:45am
UNFAIR: Mesothelioma victims must still pay for life saving treatment.
UNFAIR: Mesothelioma victims must still pay for life saving treatment.

SUFFERERS of the asbestos-related cancer mesothelioma will have to continue to pay more than $6000 for each life-saving treatment with the drug Keytruda, despite it being listed on the PBS for patients with advanced lung cancer.

Eileen Wood

Eileen Wood

Senior Journalist

I'm a senior news journalist at The Senior newspaper, the leading publication bringing targeted news on issues affecting older Australians. We cover NSW, Victoria, Queensland, Tasmania, SA and WA. If you have a story idea I would love to hear it. You can email me: eileen.wood@thesenior.com.au or phone The Senior 02-4355-5000, mob. 0487 495 805

Get the latest Senior news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.